-Reuters
Partnership/AllianceSector Analysis
GeninCode PLC Partners With Thermo Fisher Scientific For Cardio InCode-Score Manufacturing And Distribution In US And EMEA
Benzingaβ’December 04, 2025 at 8:42 AMβ’Full Content
View Original βπ Workflow Status
β CompletedCompleted in 14s
clean_raw_article
β completedβ
clean_markdown_article
β completedβ
analyze_article
β completedβ
link_article_to_stories
β skippedβ
analyze_sentiment
β completedWorkflow #2069 β’ Benzinga Article Processing
Started: 08:43:00 β’ Completed: 08:43:14
View Details βDetected Companies & Sentiment
Thermo Fisher Scientific Inc.
"strategic partnership"
9
Gist
GeninCode PLC has entered a strategic partnership with Thermo Fisher Scientific to manufacture and distribute its Cardio InCode-Score diagnostic test in the US and EMEA regions.
LLM Summary
GeninCode PLC has announced a partnership with Thermo Fisher Scientific to handle the manufacturing and distribution of its Cardio InCode-Score cardiovascular diagnostic test across the United States and Europe (EMEA). The collaboration aims to expand market reach and commercialization of the test, leveraging Thermo Fisherβs global distribution network and manufacturing capabilities.
Full Article Content
Metadata
Author:
Benzinga Newsdesk
Tickers:
TMO
Updated At:
December 04, 2025 at 4:42 AM
Benzinga Channels:
News
Teaser:
-Reuters
Benzinga Stocks:
TMO (NYSE)
Benzinga Article ID:
49202538